13F

Stock

Anbio Biotechnology

NNNN · held by 8 managers

Reported value

$1.29M

Holders

8

+3 new · −0 exited

Holders’ est. mark

−$130.3K

Price effect on 5 books still in the name

Largest holder

$661.9K

GEODE CAPITAL MANAGEMENT, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
GEODE CAPITAL MANAGEMENT, LLC25.8K$661.9K−$112.8KCut−$112.8K
BNP PARIBAS FINANCIAL MARKETS10.4K$267.2K−$4.38KAdded$237.1K
MORGAN STANLEY7.34K$188.5K−$123Added$187.7K
UBS Group AG6.34K$162.8K−$12.5KAdded$77.2K
EverSource Wealth Advisors, LLC266$6.83KNew
WELLS FARGO & COMPANY/MN100$2.57K−$438Cut−$438
Bare Financial Services, Inc15$385New
Blue Trust, Inc.5$128New

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.